Reckitt Settles Multistate Suboxone Claims for $700 Million

Reckitt Benckiser (RB Group) has agreed to pay $700 million to settle multiple lawsuits filed by states in federal courts over marketing practices for its addiction treatment drug Suboxone (buprenorphine).
Source: Drug Industry Daily